Discussion - Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
Educational information
This discussion is part of a series titled "Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA"..
Faculty
Johannes Mann is professor of medicine at the University of Erlangen-Nürnberg, and affiliated at the KfH Kidney Center, Munich, Germany
Filip Krag Knop, MD, PhD, Professor of endocrinology and Director of Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark.
Katherine Tuttle is Clinical Professor of Medicine, Nephrology, University of Washington at Spokane, WA, USA.
Disclosures
The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
This educational activity is intended for an international audience of non-US and non-UK HCPs
Funding
Funding for this educational program was provided by an unrestricted educational grant received from Novo Nordisk A/S.
Share this page with your colleagues and friends: